Daily Stock Analysis, IRIX, IRIDEX Corp, priceseries

IRIDEX Corp. Daily Stock Analysis
Stock Information
Open
1.92
Close
2.26
High
2.40
Low
1.90
Previous Close
1.91
Daily Price Gain
0.35
YTD High
5.69
YTD High Date
May 29, 2019
YTD Low
1.50
YTD Low Date
Sep 25, 2019
YTD Price Change
-2.51
YTD Gain
-52.62%
52 Week High
5.69
52 Week High Date
May 29, 2019
52 Week Low
1.50
52 Week Low Date
Sep 25, 2019
52 Week Price Change
-2.49
52 Week Gain
-52.42%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
May 8. 2018
6.41
May 29. 2018
7.02
14 Trading Days
9.54%
Link
LONG
Jul 18. 2018
6.70
Aug 1. 2018
7.10
10 Trading Days
6.01%
Link
LONG
Aug 22. 2018
8.19
Sep 7. 2018
8.76
11 Trading Days
6.96%
Link
Company Information
Stock Symbol
IRIX
Exchange
NasdaqGM
Company URL
http://www.iridex.com
Company Phone
6509404700
CEO
William M. Moore
Headquarters
California
Business Address
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA 94043
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001006045
About

IRIDEX Corp. engages in the development and commercialization of products and procedures used to treat sight-threatening eye conditions. Its products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes. It operates through the following geographical segments: United State, Europe, Rest of Americas, and Asia/Pacific Rim. he company was founded by Eduardo Arias, Theodore A. Boutacoff, and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.

Description

IRIDEX Corporation provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. The company offers laser consoles, such as Cyclo G6 laser system used for the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser systems, which are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. It also provides delivery devices, including TxCell scanning laser delivery system that allows the physicians to perform multi-spot pattern scanning; Slit Lamp Adapter, which allows the physicians to utilize a standard slit lamp in diagnosis and treatment procedures; and TruFocus laser indirect ophthalmoscopes for use in procedures to treat peripheral retinal disorders. In addition, the company offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system that delivers laser to treat glaucoma; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe Illuminate that is used in procedures to treat refractory glaucoma; and EndoProbe family of products used in vitrectomy procedures. It serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. IRIDEX Corporation markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.